Human placental stem cells induce a novel multiple myeloid cell-driven immunosuppressive program that ameliorates proinflammatory CNS pathology
Authors:
- Heela SarlusHSHeela Sarlus
- Yuxi GuoYGYuxi Guo
- Stefan BencinaSBStefan Bencina
- Keying ZhuKZKeying Zhu
- Vijay Joshua BalasinghVBVijay Joshua Balasingh
- Giulia Adriana VirgilioGVGiulia Adriana Virgilio
- Yufei ChengYCYufei Cheng
- Jianing LinJLJianing Lin
- Jin-Hong MinJMJin-Hong Min
- Irene Benito-CuestaIBIrene Benito-Cuesta
- Valerie SuerthVSValerie Suerth
- Paula Trigo AlonsoPAPaula Trigo Alonso
Preprint
Abstract
Despite a growing interest in Amniotic Epithelial Cell (AEC)-based therapies, the immune responses triggered by AEC transplantation in vivo remain poorly characterized. In particular, how direct exposure to AECs within the central nervous system (CNS) shapes the local immune environment is currently unknown. Herein we describe a novel CNS- specific immunoregulatory pathway induced by intracisternal delivery of human AECs. Local immune responses induced by AECs in the brain led to recruitment of immunosuppressive Arginase 1 + (ARG1 + ) macrophages and a novel population of myeloid-derived suppressor cells with eosinophilic characteristics, which we term Eo- MDSCs. We further demonstrate that Eo-MDSCs produce Maresin 2 (MaR2), a specialized pro-resolving mediator (SPM) involved in the resolution of inflammation. In a mouse model of Multiple Sclerosis (MS), treatment of established disease with AECs induced immunological responses that resulted in reduced numbers of pathogenic macrophages and T helper (T H )17 cells, increased anti-inflammatory T cell subsets, and enhanced myelin phagocytosis, all of which led to functional recovery. These findings suggest that AEC therapy has the potential to target CNS-intrinsic inflammatory processes in MS, providing a strong rationale for translation into the clinic.Keywords
Funding Information
- Alltid Litt Sterkere
- Karolinska Institutet KID Funding
- NEURO Stockholm
- Ollie and Elof Ericssons Foundation
- Swedish Neurofonden
- Loo and Hans Osterman Foundation for Medical Research
- Eva and Oscar Ahréns foundation
- Karolinska Fonder
- Gunvor och Josef Anérs stiftelse
- MS forskningsfonden
This publication has 71 references indexed in Scilit:
- BTK inhibition limits microglia-perpetuated CNS inflammation and promotes myelin repairActa Neuropathologica, 2024
- Myeloid‐derived suppressor cells in the therapy of autoimmune diseasesEuropean Journal of Immunology, 2023
- Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosisActa Neuropathologica, 2023
- Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiationGlia, 2020
- First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety StudyStem Cells Translational Medicine, 2018
- Adoptive transfer of cytokine‐induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 miceGlia, 2014
- Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by LaquinimodThe American Journal of Pathology, 2012
- Multiple sclerosis: Distribution of inflammatory cells in newly forming lesionsAnnals of Neurology, 2009
- Human Amniotic Epithelial Cells Produce Dopamine and Survive after Implantation into the Striatum of a Rat Model of Parkinson's Disease: A Potential Source of Donor for Transplantation TherapyExperimental Neurology, 2000
- Monocyte/macrophage differentiation in early multiple sclerosis lesionsAnnals of Neurology, 1995